-
We detected your language preference as English. Would you like to switch to the English version for a better experience?
Switch to English
Stay here
Material & Category Comparison | Procurement Guide
A clear technical comparison for procurement, QA, formulation and education teams deciding between IGF-1 LR3 and IGF-1.
IGF-1 is insulin-like growth factor 1: the 70-residue (mature 153 aa gene product) polypeptide mediator of GH action, whereas IGF-1 LR3 is the long-R3 IGF-1 analog with L-Arg3 substitution and a 1-Res extension to raise receptor selectivity and half-life. They are not the same material: the distinctions shown below determine how each is specified, verified and procured.
The practical difference is the level of control required: categories are specified by agreed markers, not molecular constants. For ordering and specification purposes, treat each side with its own description, acceptance criteria and documentation set rather than as interchangeable labels.
| Comparison Parameter | IGF-1 LR3 | IGF-1 |
|---|---|---|
| Identity basis | Category/definition, not a single substance | Category/definition, not a single substance |
| CAS Registry Number | Not applicable (category or concept, no single CAS) | Not applicable (category or concept, no single CAS) |
| Distinguishing features | native IGF-1 primary sequence with three disulfide-linked domains | Leu6-Arg3 LR3 sequence modification |
| Typical procurement focus | agreed description and marker/spec controls | agreed description and marker/spec controls |
Category terms are defined by their controlling properties; specification language, not the label alone, determines what arrives on pallet.
IGF-1 insulin-like growth factor 1: the 70-residue (mature 153 aa gene product) polypeptide mediator of GH action. The practical definition matters because the term determines native IGF-1 primary sequence with three disulfide-linked domains; specifications for igf-1 therefore rely on intact-mass by MS, biological potency, aggregation by SEC rather than on a molecular formula.
In purchasing terms, control intact-mass by MS, biological potency, aggregation by SEC at the specification level; do not rely on the label name alone.
IGF-1 the long-R3 IGF-1 analog with L-Arg3 substitution and a 1-Res extension to raise receptor selectivity and half-life. The practical definition matters because the term determines Leu6-Arg3 LR3 sequence modification; specifications for igf-1 lr3 therefore rely on sequence-variant control, disulfide integrity and potency rather than on a molecular formula.
In purchasing terms, control sequence-variant control, disulfide integrity and potency at the specification level; do not rely on the label name alone.
Both terms trace to the same naming root ("igf-1..."), which is precisely why procurement systems can confuse them. Identity must be fixed by CAS number, molecular formula and an orthogonal confirmatory test — never by name similarity.
Specification implication
Do not accept a name where a number belongs: every purchase decision here should rest on a written specification with a defined test method and reportable limit.
IGF-1 is a category or role concept; IGF-1 LR3 answers a different question. Write the specification at the level the reader will actually test.
IGF-1 LR3 is a category or role concept; IGF-1 answers a different question. Write the specification at the level the reader will actually test.
Cross-category substitutions look tempting on paper and fail in audits. Any use that touches ingestion, injection, skin exposure or regulated discharge requires a purpose-specific qualification record, not a research-grade label.
Grade names mean nothing without a defined specification, intended use and documented controls; a certificate image on a quotation does not demonstrate compliance for the application you are buying for.
| Industry / Use | Target Grade | Essential Documentation and Checks |
|---|---|---|
| API or regulated drug-substance use (where applicable) | Applicable pharmacopoeial or justified in-house specification | Current specification and batch certificate, GMP evidence, site details, change control, stability, impurity controls and DMF/CEP status where applicable. |
| Pharmaceutical or fine-chemical intermediate | Process-qualified chemical grade | Identity, assay, related substances, residual solvents, traceability and risk-based qualification under confidentiality where needed. |
| Food, feed or cosmetic ingredient (where listed) | Use-specific qualified grade | Ingredient identity confirmation (INCI/food listing), SDS, specification, contaminants assessment and destination-market regulatory review. |
| Research-grade / laboratory use | Defined research grade with stated limits | Identity and assay, relevant bioburden or endotoxin data only where required, lot consistency and documented suitability for the specified assay. |
| Industrial / technical use | Technical grade matched to process tolerances | Key functional numbers (pH, assay, moisture, viscosity/activity), packaging integrity, and supply reliability rather than compendial language. |
Regulatory note: category-level materials are controlled by use-specific rules (food additive, cosmetic ingredient, industrial listing). Confirm the listing status for the exact material and destination market before relying on it.
Review the actual methods, reporting limits and acceptance criteria behind every certificate line, selected against the production route and intended use — a generic report tests neither every listed impurity nor every relevant risk.
| QC Attribute | IGF-1 LR3: Audit Focus | IGF-1: Audit Focus | Recommended Verification |
|---|---|---|---|
| Identity | insulin-like growth factor 1: the 70-residue (mature 153 aa gene product) polypeptide mediator of GH action | the long-R3 IGF-1 analog with L-Arg3 substitution and a 1-Res extension to raise receptor selectivity and half-life | Orthogonal identity methods such as FTIR plus a validated chromatographic or spectrometric method, or the marker test named in the specification. |
| Assay & related substances | the agreed marker assay plus intact-mass by MS, biological potency, aggregation by SEC | the agreed marker assay plus sequence-variant control, disulfide integrity and potency | Validated assay with reporting limit, impurity identification and quantitation justified by route or process. |
| Residual solvents / process residues | declared processing solvents or extraction residues | declared processing solvents or extraction residues | Headspace GC-FID or GC-MS against ICH Q3C limits plus a process-specific solvent risk assessment. |
| Water and inorganic residue | water content, sulfated ash/residue on ignition, counterion balance where ionic | water content, sulfated ash/residue on ignition, counterion balance where ionic | Karl Fischer where appropriate; compendial or validated residue test. |
| Elemental impurities | risk-based metals from catalysts, reagents and equipment | risk-based metals from catalysts, reagents and equipment | ICP-MS/ICP-OES where risk assessment and applicable standards warrant testing. |
| Microbiological / allergen quality | as required by intended application | as required by intended application | Bioburden, endotoxin, pathogen or allergen controls only where justified by the intended use and product specification. |
These are risk-based audit targets, not claims about any specific lot; the producer’s validated methods and limits govern.
Procurement warning: a shared "igf-1" naming root invites substitution errors.
A high-purity lot of the wrong side can arrive when the process actually required the other; quotation review and master-data entry skim over the difference, producing a wrong molar charge, a failed assay or a formulation that cannot perform.
Prevention: put the exact name, identifier (CAS where applicable), grade, specification and intended application on the PO; at incoming inspection reconcile label, certificate, identity test and material master. Never release on a single attribute.
Category materials are produced, blended and bottled in many jurisdictions; origin tells you almost nothing about composition. Qualify the documented control system instead.
Qualify a second source only after comparing descriptions, methods, impurity/marker profiles, packaging and lead times: a supplier change can alter exactly the characteristics this comparison warns about.
| Control | Procurement Recommendation |
|---|---|
| Primary packaging | Supplier-qualified, tightly closed containers compatible with the material and destination use: HDPE or glass where moisture/light justification exists, with validated liners and tamper-evident closures. |
| Moisture and light | Follow documented protection requirements; do not infer amber-glass or desiccant needs without stability justification. |
| Temperature | Use the specification/label storage range; excursion tolerance should rest on stability data, not on habit. |
| Traceability | Sealed original packaging, batch identification, shipping-condition records where specified, and a documented excursion assessment; for sterile or biologically sensitive uses, qualify additional controls separately. |
Include the following in every request for quotation to reduce mismatches and qualification delays.
B2B Chemical Sourcing
Compare suppliers, request quotations and evaluate batch documentation before committing to a purchase. Fix the identifier and required grade first, then qualify the supplier against your technical and regulatory requirements.
Request current certificates, specifications, impurity methods and regulatory documents directly from shortlisted suppliers. Availability and listing details must be independently verified.
For the molecular side, the CAS number and approved specification define identity; for the category side, the written description and marker test do. A quotation line quoting the other level is the root cause of most disputes in this comparison.
Make incoming inspection test the level the PO named: identity plus assay for substances; description, marker and contaminant limits for categories.
Only if the acceptance test produces the same result for both, which in practice they never do: one term is verified by identity/assay of a substance, the other by description and marker.
Write the specification around the outcome you need to test for, then name exactly one side of this comparison as the contract term.
Category materials are usually governed by moisture, temperature range, contamination and shelf-life language in their own specs. Uniformity of sampling and label integrity on every unit ship the practical audit points.
Document the storage class in the material master so downstream users inherit the same assumptions.
A current certificate of analysis from the actual manufacturing site (not a template), the specification with methods and limits, the safety data sheet for the destination market, and identity confirmation by an orthogonal test. For regulated uses add the relevant registration, listing or dossier authorization and a change-notification commitment in writing.
Confirm that the documents cover the exact material, grade and site you are buying; certificates that describe a sister product are the most common near-miss in this comparison.
Editorial and compliance note
This article provides technical and procurement guidance, not a substitute for an approved product specification, regulatory assessment or validated analytical procedure. Cited databases support identification; they do not independently establish a supplier’s grade, compliance status, batch purity or commercial availability. Verify all certificates, listings and current requirements before purchase or publication.
EN
Agricultural News
Food News
Industrial News
Cosmetic News
Pharmaceutical News
Science News
